Low-Density Lipoprotein Cholesterol-Reference-Cited by-同舟云学术

Low-Density Lipoprotein Cholesterol

Published:2020-05 Issue:17 Volume:75 Page:2119-2121
ISSN:0735-1097
Container-title:Journal of the American College of Cardiology
language:en
Short-container-title:Journal of the American College of Cardiology

Author:

Cannon Christopher P.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference24 articles.

1. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins;Baigent;Lancet,2005

2. Effects of cholesterol-lowering with simvastatin on stroke and other major vascular events in 20536 people with cerebrovascular disease or other high-risk conditions;Collins;Lancet,2004

3. Intensive versus moderate lipid lowering with statins after acute coronary syndromes;Cannon;N Engl J Med,2004

4. Intensive lipid lowering with atorvastatin in patients with stable coronary disease;LaRosa;N Engl J Med,2005

5. Design of the Pravastatin or Atorvastatin Evaluation and Infection Therapy (PROVE IT) - TIMI 22 Trial;Cannon;Am J Cardiol,2002

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Risk of new-onset diabetes with high-intensity statin use;The Lancet Diabetes & Endocrinology;2024-09

2. Early administration of proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors in patients with acute coronary syndrome: a systematic review and meta-analysis;BMC Cardiovascular Disorders;2024-07-30

3. Low-Density Lipoprotein Cholesterol, Cardiovascular Disease Risk, and Mortality in China;JAMA Network Open;2024-07-18

4. Guía latinoamericana de recomendaciones al egreso de un síndrome coronario agudo;Archivos de Cardiología de México;2024-06-05

5. Evolving Concepts of the SCORE System: Subtracting Cholesterol from Risk Estimation: A Way for a Healthy Longevity?;Life;2024-05-24